Netflix Swings After Reporting… And Trump Takes Aim At Powell 4/17/25
CNBC's "Fast Money"
00:00
Eli Lilly's Obesity Pill: A Game Changer in Diabetes Treatment
This chapter explores the rise of Eli Lilly's stock due to positive late-stage trial results for its obesity pill aimed at type 2 diabetes patients. It examines the pill's advantages, expert insights on patient preferences, and the critical role of pricing in its market performance.
Transcript
Play full episode
